Gematologiya i Transfuziologiya

Papers
(The TQCC of Gematologiya i Transfuziologiya is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Thermolability of factor VIII in donor fresh frozen blood plasma8
Cytogenetic and molecular genetic diagnostics in oncohematological disorders: a position paper of the Organization of Molecular Geneticists in Oncology and Oncohematology8
Minimal residual disease and b-cell subpopulation monitoring in acute b-lymphoblastic leukaemia patients treated on rall-2016 protocol4
Mechanisms of action of immunomodulatory drugs — from teratogenicity to treatment of multiple myeloma4
Risk-adapted combined therapy with arsenic trioxide and all-trans-retinoic acid for de novo acute promyelocytic leuкaemia4
Thrombotic thrombocytopenic purpura in pregnancy. Giving birth or not giving birth, that is the question4
National clinical recommendations for the diagnosis and treatment of mastocytosis4
Detection of measurable residual disease in adults with acute leukaemia4
Clinical guidelines for the management of patients with paroxysmal nocturnal hemoglobinuria3
A prospective study of the monitoring of patients with chronic myeloid leukemia upon withdrawal of tyrosine kinase inhibitor therapy3
Observation in a treatment-free remission in chronic myeloid leukemia patients with a stable deep molecular response in the Russian portion of the international multicenter population based study EUTO3
Structure and prognostic signifi cance of 13q14 deletion in chronic lymphocytic leukemia3
Oligoclonality and subpopulation structure of bone marrow T-cells in patients with aplastic anaemia3
Comparison of the treatment results in adult patients with acute Ph-negative lymphoblastic leukemia on protocols of the Russian multicenter studies ALL-2009 and ALL-20163
Immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura — diagnostic difficulties and errors3
Diagnosis and choice of haemostatic therapy during surgery in patients with combined coagulation factor V and VIII defi ciency3
Structure and signifi cance of cytogenetic abnormalities in patients with multiple myeloma2
Immunoglobulin genes and stereotyped antigenic receptors in chronic lymphocytic leukemia and other lymphoproliferative diseases2
Interim results of the PML-16, PML-19 protocols for primary mediastinal large B-cell lymphoma therapy2
Myeloidderived peripheral blood suppressor cells at haematopoietic stem cell mobilisation in multiple myeloma patients2
Chimeric antigen receptor T-cell therapy in adult patients with B-cell lymphoproliferative diseases2
Treatment tactics for a patient with acquired hemophilia: continuous infusion of recombinant activated coagulation factor VII and the inhibitor eradication2
Next-generation sequencing-based molecular genetic profiling in adults with acute myeloid leukaemia2
Methodological aspects of the detection of minimal residual disease in patients with acute leukemia2
The role of D-dimer in stroke risk stratification in patients with atrial fibrillation2
Endothelial-platelet interaction in sepsis2
Next generation sequencing HLA-typing of recipients and donors of allogeneic haematopoietic stem cells2
Coexistence of multiple myeloma and chronic myeloleukosis in one patient2
A long-term follow-up of observation in treatment-free remission in patients with chronic myeloid leukemia1
Vaccination against COVID-19 for hematologic patients: A review of clinical guidelines1
Molecular and genetic verification of von Willebrand disease type 2N1
Impact of natural killer cell’s functional reconstruction on the results of allogeneic hematopoietic stem cell transplantation1
Combination of ibrutinib and venetoclax followed by Chimeric Antigen Receptor T-cell therapy in the first line of treatment in an elderly patient with mantle cell lymphoma with hyperleukocytosis and mu1
Using a thrombodynamics test for diagnostics of hypercoagulation and prediction of thromboembolic complications in patients with malignant tumors1
Management of immune thrombocytopenia during COVID-19 pandemic1
Supplement intravenous iron therapy in cardiac surgery1
First experience of allogeneic haematopoietic stem cell transplantation in patients with mantle cell lymphoma with a mutation in the <i>TP53</i> gene1
Effect of low concentration of melatonin on the quality of stored red blood cells <em>in vitro</em>1
Kaposi’s sarcoma in HIV-negative patient with primary myelofi brosis1
Regional hematology service registration system for the Russian Federation1
Optimal blood management as priority route in cardiac surgery1
Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute leukemia1
Successful treatment of relapses of primary mediastinal large B-cell lymphoma with central nervous system involvement1
Management of patients with hemophilia A on emicizumab prophylactic treatment: Recommendation from Russian Experts1
COVID-19 in patients with congenital bleeding disorders in Russia1
Contribution of social and demographic parameters to the long-term survival prognosis of chronic myeloid leukemia patients1
Obinutuzumab in combination with chlorambucil in first line treatment of elderly patients with chronic lymphocytic leukemia1
Role of the intensive care in allogeneic hematopoietic stem cell transplantation1
Identifi cation of ABO, RH and KEL blood group antigens with serology and genotyping methods1
Whole-body magnetic resonance imaging for diagnosis and treatment monitoring in multiple myeloma1
Infectious complications and their contributing risk factors after allogeneic hematopoietic stem cell transplantation1
Significance of TPMT and NUDT15 variants in 6-mercaptopurine metabolism in acute lymphoblastic leukaemia/lymphoma patients1
The incidence of impaired binding capacity of von Willebrand factor to collagen types I and III in patients with type 1 von Willebrand disease1
Dynamic laboratory control of iron deficiency correction in neurosurgical patients1
Conformational disorders of RBC membranes during long-term storage1
COVID-19 infection in patients undergoing allogeneic hematopoietic stem cell transplantation1
Characteristics and trends in the work of the Blood Service of the Russian Federation in 2016–20201
The incidence of Ph-negative chronic myeloproliferative neoplasms in Belarus1
Anemia in primary hyperparathyroidism1
Physiological and pathological role of factor XII1
Advantages and disadvantages of femoral port systems in hematоlogical patients with superior vena cava syndrome1
Blood groups and acute respiratory viral infection COVID-191
Minor histocompatibility antigens as targets for T-cell immunotherapy1
Hemophilia in the city of Novosibirsk and Novosibirsk region: Clinical phenotype, comorbidity1
Cytokines in the mechanisms of regulation of monocytopoiesis in ischemic heart disease1
Clonal hematopoiesis and its role in the development of hematological diseases1
Experience of haematological observatory ward during COVID-10 pandemic1
0.028552055358887